About Selmod
Selmod is a company based in Basel (Switzerland) founded in 2016.. Selmod has raised $10.15 thousand across 1 funding round from investors including Venture Kick. Selmod offers products and services including Innovative Antibiotics and Antimicrobial Peptides. Selmod operates in a competitive market with competitors including Scynexis, F2g, Amplyx Pharmaceuticals, Viamet Pharmaceuticals and Elion Therapeutics, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Selmod Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.15 K (USD)
in 1 rounds
-
Latest Funding Round
$10.15 K (USD), Seed
Jun 01, 2016
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Selmod
Selmod offers a comprehensive portfolio of products and services, including Innovative Antibiotics and Antimicrobial Peptides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small molecules and peptides targeting multi-drug resistant infections.
Peptides for new mechanisms against established infection targets.
Funding Insights of Selmod
Selmod has successfully raised a total of $10.15K through 1 strategic funding round. The most recent funding activity was a Seed round of $10.15 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $10,152
-
First Round
First Round
(01 Jun 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Seed - Selmod | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Selmod
Selmod has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Selmod
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Selmod
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Selmod Comparisons
Competitors of Selmod
Selmod operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scynexis, F2g, Amplyx Pharmaceuticals, Viamet Pharmaceuticals and Elion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developing glucan synthase inhibitors for the treatment of fungal infections.
|
|
| domain | founded_year | HQ Location |
Drugs for systemic fungal diseases are discovered and developed.
|
|
| domain | founded_year | HQ Location |
Broad-spectrum fungal enzyme inhibitors are developed by clinical-stage biopharma.
|
|
| domain | founded_year | HQ Location |
Therapies for chronic fungal infections are developed using metalloenzyme inhibitors.
|
|
| domain | founded_year | HQ Location |
Therapeutics for invasive fungal infections are developed by Elion Therapeutics.
|
|
| domain | founded_year | HQ Location |
Anti-fungal therapeutics are developed against invasive fungal diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Selmod
When was Selmod founded?
Selmod was founded in 2016.
Where is Selmod located?
Selmod is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Is Selmod a funded company?
Selmod is a funded company, having raised a total of $10.15K across 1 funding round to date. The company's 1st funding round was a Seed of $10.15K, raised on Jun 01, 2016.
What does Selmod do?
Selmod was founded in 2016 as a spin-out from the University of Basel, Switzerland, focusing on the biotech sector. Operations center on preclinical development of innovative small molecule antifungals targeting life-threatening invasive fungal infections. The lead compound, AB-284, derived from plant sources, is advanced in preclinical stages. Grants have been secured from the Swiss Federal Commission for Technology and Innovation, Venturelab, and VentureKick, with the company located in Basel.
Who are the top competitors of Selmod?
Selmod's top competitors include Scynexis, F2g and Amplyx Pharmaceuticals.
What products or services does Selmod offer?
Selmod offers Innovative Antibiotics and Antimicrobial Peptides.
Who are Selmod's investors?
Selmod has 1 investor. Key investors include Venture Kick.